RUSSELL RYAN LAB

Targeting cancer gene regulation in lymphoid malignancies

Home: Overview

RESEARCH

Flipping the switch on driver oncogenes

Home: Research

B CELL LYMPHOMAS AND LEUKEMIAS

Cancers that develop from B cells affect patients of all ages, and are diverse in their biology and clinical behavior. By uncovering the unique dependencies of specific leukemia and lymphoma subtypes, we seek to define more effectively tailored treatment strategies for individual cancer patients.

ONCOGENE ENHANCERS

We use a combination of genome-wide chromatin profiling technologies and high-throughput Cas9-based functional screening approaches to dissect the mechanisms that sustain expression of genes critical for the growth and survival of lymphoid cancers

NOTCH SIGNALING

Mutations in Notch receptor genes are recurrent in several types of lymphoid cancer, but the mechanisms by which Notch drives mature B cell lymphomas remains poorly understood. We identified genome-wide direct targets of Notch in mature B cell cancers, and are working to understand the process by which the Notch regulome sustains lymphoma.

Want to learn more about our research projects?

NEWS

What we're up to

WE'RE MOVING!

September 2018

The Ryan lab is moving from the LSI to our new home on the 4th floor of the Rogel Cancer Center building. We're excited to be located in the heart of the U-M Medical Campus, and to explore collaborations with our new neighbors in Pathology and Hematology-Oncology.